Skip to main content

SYSTEMATIC REVIEW article

Front. Immunol.
Sec. Inflammation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1519534
This article is part of the Research Topic Inflammation and Immune Factors in Venous Thromboembolism View all 4 articles

Association of Post-Thrombotic Syndrome with Metabolic Syndrome and Inflammation -A Systematic Review

Provisionally accepted
Sara Alturky Sara Alturky *Yusuf Ashfaq Yusuf Ashfaq Ajit Elhance Ajit Elhance Ishaq Wadiwala Ishaq Wadiwala Anna K Hunter Anna K Hunter Khanh Nguyen Khanh Nguyen
  • Oregon Health and Science University, Portland, United States

The final, formatted version of the article will be published soon.

    Post-thrombotic syndrome (PTS) is a chronic complication of deep vein thrombosis (DVT). Given its impact on vascular health, understanding risk factors for the development of PTS, as well as conditions such as metabolic syndrome that may contribute to vascular inflammation, is crucial. Metabolic syndrome is a constellation of factors that increase cardiovascular disease risk, insulin resistance, diabetes mellitus (DM), and cerebrovascular disease. Despite the established connection between metabolic syndrome and venous thromboembolism (VTE), the association between metabolic syndrome and PTS has yet to be explored.A literature search identified studies regarding PTS and metabolic syndrome and the individual components of metabolic syndrome. A specialist performed the search, and studies were identified through PubMed, Ovid Medline, and Cochrane in accordance with PRISMA guidelines. Search terms included "post-thrombotic syndrome" and "metabolic syndrome" as well as "obesity," "hyperglycemia," "hypertension," "dyslipidemia," and "insulin resistance." Two people independently screened articles and consolidated differences. Abstractonly studies, review articles, case studies, and conference abstracts were excluded. Case reports, literature reviews, and studies not discussing PTS were excluded. Prospective cohort, retrospective cohort, and casecontrol studies were included. All English-based studies that met inclusion criteria published before January 3rd, 2024, were included. 281 articles were initially identified. After abstract and title screening, 16 articles underwent full-text review.Of the 16 articles that underwent review, nine were included in the final analysis. Among the selected articles, eight out of nine mentioned obesity as a risk factor for developing PTS, making it the most common component mentioned. Hypertension, diabetes mellitus, hyperlipidemia, and low high-density lipoprotein (HDL) followed in prevalence. There was no noted difference between inflammatory markers in patients with and without PTS.Metabolic syndrome and its components, individually and in association with PTS, are not commonly examined. Eight articles examined the association of obesity with the development of PTS. This review identified a strong association between obesity, particularly abdominal or visceral obesity, and the development of PTS. While the association between PTS and VTE is established, further research is needed to identify the role of metabolic syndrome in the development of PTS.

    Keywords: Post-Thrombotic Syndrome1, metabolic syndrome2, Deep Vein Thrombosis3, Venous Thromboembolism4, inflammation5, Vascular6, Obesity7

    Received: 30 Oct 2024; Accepted: 06 Feb 2025.

    Copyright: © 2025 Alturky, Ashfaq, Elhance, Wadiwala, Hunter and Nguyen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sara Alturky, Oregon Health and Science University, Portland, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.